Income Statement
MINERVA NEUROSCIENCES, INC.
NERV
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue
|
- | - | - | - | - | 41.18 | - | - | - | - | - | - |
|
Cost of Revenue
|
- | - | - | - | - | - | - | - | - | - | - | - |
|
Gross Profit
|
- | - | - | - | - | 41.18 | - | - | - | - | - | - |
|
Operating Expenses
|
15.10 | 21.85 | 23.12 | 25.23 | 45.37 | 39.33 | 75.87 | 51.73 | 41.17 | 30.19 | 26.11 | 54.87 |
|
Research & Development
|
5.76 | 11.90 | 12.71 | 14.65 | 32.04 | 22.04 | 58.12 | 34.89 | 30.26 | 20.44 | 18.53 | 42.91 |
|
Selling, General & Administrative
|
9.34 | 9.95 | 10.41 | 10.58 | 13.33 | 17.29 | 17.74 | 16.84 | 10.91 | 9.75 | 7.58 | 11.96 |
|
Other Operating Expenses
|
- | - | - | - | - | - | - | - | - | - | - | - |
|
Operating Income
|
-15.10 | -21.85 | -23.12 | -25.23 | -45.37 | 1.85 | -75.87 | -51.73 | -41.17 | -30.19 | -26.11 | -54.87 |
|
Non-Operating Income
|
- | - | - | 6.88 | 6.34 | -0.09 | -1.43 | -1.56 | -0.27 | - | - | - |
|
Interest Income
|
0.95 | 1.27 | 1.44 | 0.56 | 0.02 | 0.16 | 1.46 | 1.67 | 0.94 | 0.20 | 0.10 | - |
|
Interest Expense
|
- | - | - | - | - | - | - | 0.10 | 0.60 | 1.00 | 1.10 | 2.00 |
|
Other Non-Op Income / Expense
|
- | - | - | - | - | - | - | - | - | - | - | - |
|
Income Before Tax
|
- | - | - | -32.11 | -51.71 | 1.94 | -74.44 | -50.17 | -40.90 | - | - | - |
|
Income Tax Expense
|
- | - | - | 0.00 | -1.80 | 0.00 | -2.25 | 0.00 | -9.38 | - | - | - |
|
Non-Controlling Interest
|
- | - | - | - | - | - | - | - | - | - | - | - |
|
Net Income
|
-293.42 | 1.44 | -30.01 | -32.11 | -49.91 | 1.94 | -72.18 | -50.17 | -31.52 | -31.05 | -27.08 | - |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - | - | - | - | - | - | - | - |
|
EBITDA
|
-15.10 | -21.84 | -23.11 | -25.23 | -45.37 | 1.86 | -75.85 | -51.71 | -41.16 | -30.17 | -26.09 | -54.84 |
|
Earnings Per Share (Basic)
|
-34.67 | 0.19 | -4.61 | -6.01 | -1.17 | 0.05 | - | - | - | - | - | - |
|
Diluted EPS
|
-34.67 | 0.19 | -4.61 | -6.01 | -1.17 | 0.05 | - | - | - | - | - | - |
|
Weighted Average Shares
|
8.46 | 7.57 | 6.51 | 5.34 | 42.72 | 40.82 | - | - | - | - | - | - |
|
Diluted Weighted Avg Shares
|
8.46 | 7.57 | 6.51 | 5.34 | 42.72 | 40.92 | - | - | - | - | - | - |
|
Comprehensive Income
|
- | - | - | - | - | - | - | - | - | - | - | - |